NCT01201603

Brief Summary

The aim of this study is primarily to investigate the ability of antioxidants found in orange juice (OJ) to increase the body's sensitivity to the hormone insulin. Overweight or mildly obese women, who are otherwise healthy, will be recruited. The time commitment for subjects is \~14wks. Subjects will attend the laboratory on 5 occasions after fasting from midnight. The 1st is a medical screening. Laboratory visits 2 \& 5 will take \~5hrs and will be separated by 3 months, during which time subjects will consume 250ml of an orange drink (either OJ or an orange flavoured control drink) once a day. During visits 2 \& 5, subjects will have a scan to assess their %body fat using a low-dose x-ray machine, and have their insulin sensitivity measured using a technique called a 'Glucose Clamp'. During the 3hr glucose clamp, subjects receive an infusion of the hormone insulin and a glucose solution directly into their blood stream, with insulin sensitivity determined from the amount of glucose required to maintain blood glucose at normal levels. In addition, a small sample of fat tissue (about the size of a haricot bean) will be taken from underneath the skin of the belly. Subjects will record their food intake for 3-days in weeks 3, 7 and 11 of consuming the drink, and come to the lab for visits 3\&4 during weeks 4\&8. Laboratory visits 3\&4 repeat measurements taken in the 1st (screening) visit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 14, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

1.4 years

First QC Date

September 13, 2010

Last Update Submit

November 26, 2025

Conditions

Keywords

WomenOrange JuiceInsulin ResistanceObesity

Outcome Measures

Primary Outcomes (1)

  • Insulin sensitivity ('M' value)

    Insulin sensitivity (mg glucose disposal from the blood/kg body weight/min)calculated from glucose disposal during a hyperinsulinemic, euglycemic glucose clamp

    after 3 months' intervention

Secondary Outcomes (4)

  • Glucose Oxidation rate

    after 3 months' intervention period

  • High Density Cholesterol

    after 3 months' intervention

  • Low density cholesterol

    after 3 months' intervention

  • Gene expression in adipose tissue

    after 3 months' intervention

Study Arms (2)

Orange Juice

EXPERIMENTAL

Orange Juice reconstituted from frozen concerntrate

Dietary Supplement: orange juice

Orange drink

PLACEBO COMPARATOR

Sugars matched orange drink

Dietary Supplement: orange juice

Interventions

orange juiceDIETARY_SUPPLEMENT

250ml of orange juice or a sugars matched orange drink

Orange JuiceOrange drink

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • pre-menopausal or post-menopausal and taking HRT
  • BMI 27-35kg/m2
  • HOMA-IR value \> 1.5
  • healthy

You may not qualify if:

  • pregnant or breast feeding,
  • any metabolic or endocrine abnormalities,
  • clinically significant abnormalities on screening,
  • fasting glucose \> 6.0mmol/l,
  • taking medication other than the contraceptive pill or HRT
  • herbal supplement use,
  • food allergies/intolerances related to the investigational product (citrus juices, fructose)
  • daily consumption of \>100ml citrus juices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nottingham

Nottingham, Notts, NG7 2UH, United Kingdom

Location

Related Publications (3)

  • Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care. 2008 Jul;31(7):1311-7. doi: 10.2337/dc08-0080. Epub 2008 Apr 4.

    PMID: 18390796BACKGROUND
  • Fujioka K, Greenway F, Sheard J, Ying Y. The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. J Med Food. 2006 Spring;9(1):49-54. doi: 10.1089/jmf.2006.9.49.

    PMID: 16579728BACKGROUND
  • O'Neil CE, Nicklas TA. A review of the relationship between 100% fruit juice consumption and weight in children and adolescents. American Journal of Lifestyle Medicine 2(4): 315-354, 2008.

    BACKGROUND

MeSH Terms

Conditions

Insulin ResistanceObesity

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Ian A Macdonald, PhD

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Fellow

Study Record Dates

First Submitted

September 13, 2010

First Posted

September 14, 2010

Study Start

July 1, 2010

Primary Completion

December 1, 2011

Study Completion

November 1, 2013

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations